pembrolizumab,pds0101
pds biotech,merck
['headandneck', 'pdsbio', 'pds bio']
the abstract from the versatile-002 study will be presented today at #asco23 and #headandneckcancer experts will be reviewing it at e451 at 4:30-6 p.m. (ct). pds will host a webcast 6/6 at 8 am. #oncology #immunotherapy #biotech #clinicaltrials 
PDS Biotech is a clinical-stage biotech company developing cancer therapies and infectious disease vaccines based on Versamune®, a T-cell activating technology.